Synmosa Group, one of the leading pharmaceutical groups in Taiwan, owns 5 PIC/s GMP manufacturing facilities (the sixth plant is under construction), and is specialized in 5 technology platforms, including Effervescent Tablets, Nasal Sprays, HFA MDI, Hormones and Granules. With more than 10 years experience in Hong Kong, China and South-East Asia market, Synmosa expands the business network to South Korea, Middle East, South Africa and Latin America in the past few years. We are looking for licensing-in, licensing-out and OEM/ODM partners.